Consolidated Statement of Comprehensive Income For the Year Ended 30 June 2023 Consolidated Entity Notes 2023 US$m 2022 US$m Sales and service revenue 12,776 10,136 Influenza pandemic facility reservation fees 156 162 Royalties and license revenue 242 195 Other income 136 69 Total operating revenue 3 13,310 10,562 Cost of sales (6,466) (4,830) Gross profit 6,844 5,732 Research and development expenses 7 (1,235) (1,156) Selling and marketing expenses (1,454) (961) General and administration expenses (1,086) (688) Operating profit 3,069 2,927 Finance costs 3 (444) (165) Finance income 38 18 Profit before income tax expense 2,663 2,780 Income tax expense 4 (419) (525) Net profit for the year 2,244 2,255 Other comprehensive income (OCI) Items that may be reclassified subsequently to profit or loss Hedging transactions – Changes in fair value 12 – 135 – Realised in profit and loss 12 (14) (1) Exchange differences on translation of foreign operations, net of hedges on foreign investments 12 (17) (287) Items that will not be reclassified subsequently to profit or loss Changes in fair value on equity securities measured through OCI, net of tax 12 (42) (7) Actuarial gains on defined benefit plans, net of tax 19 1 35 Total other comprehensive losses (72) (125) Total comprehensive income for the year 2,172 2,130 Net profit for the year attributable to: 2,244 2,255 – Shareholders of CSL Limited 2,194 2,255 – Non-controlling interests 50 – Total comprehensive income for the year attributable to: 2,172 2,130 – Shareholders of CSL Limited 2,122 2,130 – Non-controlling interests 50 – Earnings per share (based on net profit attributable to CSL Limited shareholders for the year) US$ US$ Basic earnings per share 10 4.55 4.81 Diluted earnings per share 10 4.53 4.80 The consolidated statement of comprehensive income should be read in conjunction with the accompanying notes. CSL Limited Annual Report 2022/23 112
RkJQdWJsaXNoZXIy MjE2NDg3